Psoriasis Phase III: Fast & Focused

Caidya was engaged to provide full-service clinical research service for a pivotal Phase III trial conducted across China. Conducted under multiple stakeholders with divergent priorities, this study sought to enroll over 500 participants across approximately 40 sites, requiring meticulous coordination and stringent oversight.

Leading a new way

The latest from Caidya

Explore our news and updates as we deliver a superior customer experience.

11/20/2025

Caidya Reimagines Next Generation Clinical Trial Innovation and Study Delivery with Medidata AI-Powered Experiences

New Experiences solutions, including Medidata CTMS and Medidata Clinical Data...

09/19/2025

Caidya Appoints Dr. Bin Peng as Chair of its China Scientific Advisory Board

RALEIGH, N.C.; September 19, 2025 – Caidya, a leading global...

07/21/2025

Caidya’s John Wang Named Chair of China CDISC Coordinating Committee; Medidata Accreditation Underscores Data Management Excellence

RALEIGH, N.C.; July 22, 2025 – Caidya a global, technology-enabled clinical...
Skip to toolbar